Oxford Wealth Group’s Recursion Pharmaceuticals RXRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
2024
Q3
$309K Sell
2024
Q2
$356K Buy
2024
Q1
$106K Buy